| HOME >> BIOLOGY >> TECHNOLOGY |
Management to Host Teleconference on Monday, November 17, 2008 Beginning at 4:15 PM Eastern Time
LIVINGSTON, N.J., Nov. 11 /PRNewswire-FirstCall/ -- Milestone Scientific Inc. (OTC Bulletin Board: MLSS), the recognized leader in advanced injection technologies, today announced that the Company will report its third quarter 2008 financial results for the three and nine months ended September 30, 2008 on Friday, November 14, 2008.
Milestone Scientific will also host a teleconference on Monday, November 17, 2008, beginning at 4:15 PM Eastern Time, and invites all interested parties to join management in a discussion regarding the Company's financial results, corporate progression and other meaningful developments. The conference call can be accessed via telephone by dialing toll free 1-800-218-8862. For those unable to participate at that time, a replay of the teleconference can be accessed domestically by dialing 1-800-405-2236 and entering the passcode 11122141#. The replay will be available for 90 days.
About Milestone Scientific Inc.
Headquartered in Livingston, New Jersey, Milestone Scientific is
engaged in pioneering proprietary, highly innovative technological
solutions for the medical and dental markets. Central to the Company's IP
platform and product development strategy is its patented CompuFlo(R)
technology for the improved and painless delivery of local anesthetic.
Specifically, CompuFlo is a computer-controlled, pressure sensitive
infusion, perfusion, suffusion and aspiration technology, which provides
real-time readouts of pressures, fluid densities and flow rates, enabling
the advanced delivery and removal of a wide array of fluids. The STA(TM)
(Single Tooth Anesthesia) System, a computer-controlled local anesthesia
delivery system, uses this technology to provide dentists with audible and
visual signals as to in-tissue pressure. Milestone's existing painless
injection systems are currently sold in 25 countries. For mor
'/>"/>
| SOURCE Milestone Scientific Inc. Copyright©2008 PR Newswire. All rights reserved |